Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Conti

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Journal of Experimental & Clinical Cancer Research : CR|February 6, 2015
Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?Matteo Santoni, Alessandro Conti, Giuseppe Procopio, et al.
Plos One|August 30, 2014
Natural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis surveyDaniele Santini, Francesco Pantano, Ferdinando Riccardi, et al.
Cancers|January 8, 2020
Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic FactorsMatteo Santoni, Daniel Y Heng, Sergio Bracarda, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Journal of Experimental & Clinical Cancer Research : CR|February 6, 2015
Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?Matteo Santoni, Alessandro Conti, Giuseppe Procopio, et al.
Plos One|August 30, 2014
Natural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis surveyDaniele Santini, Francesco Pantano, Ferdinando Riccardi, et al.
Cancers|January 8, 2020
Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic FactorsMatteo Santoni, Daniel Y Heng, Sergio Bracarda, et al.
Pageof 8